Yes, people have died from asthma, including children and adults. Learn about socioeconomic variables and comorbid factors in ...

A noninvasive approach could help clinicians prescribe medications more precisely for patients according to endotype.

According to a recent study, financial constraint was a major contributor to nonadherence to medications in adults with ...

While the exact cause of asthma is unknown, certain genetic factors can increase the risk of developing the disease.

Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated.

The drugmaker also maintains that about half of asthma patients have multiple drivers of inflammation that makes treatment with current drugs like inhaled medicines and currently approved ...

PF-07832837 is under clinical development by Pfizer and currently in Phase I for Asthma. According to GlobalData, Phase I drugs for Asthma have a 74% phase transition success rate (PTSR) indication ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

Gov. Maura Healey signed two major healthcare reform bills Wednesday — one that looks to increase hospital oversight in the ...

Broncho-Vaxom is under clinical development by OM Pharma and currently in Phase I for Allergic Asthma. According to GlobalData, Phase I drugs for Allergic Asthma have a 78% phase transition success ...

Kids in Detroit may face multiple barriers to getting the care they need to keep their asthma under control, including lack ...

The first-in class medicine for severe asthma co-developed by AstraZeneca and Amgen is poised for accelerated approval after the US Food and Drug Administration granted it a breakthrough designation.